Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: carranza2 who wrote (155881)	4/3/2020 1:55:46 PM
From: TobagoJack	1 Recommendation Recommended By Dr. Voodoo Respond to of 217786

I am cautiously going long, by shorting deep out-of-the-money puts, in case i am early, so I have chance to average-in by averaging-up on premiums collected, for now Eventually shall have to wade in. Waiting for signal.

To: carranza2 who wrote (155881)	4/3/2020 5:32:52 PM
From: Pogeu Mahone	Respond to of 217786

Will the FDA want clinical trials? Dr. Rob Davidson @DrRobDavidson Apr 1 Replying to @DrOz The CT scan data is a proxy endpoint, and a day less of fever and cough does not justify its use. We need mortality data, time in ICU data, complications data. ........................................................................................................... Coronavirus: Dr. Anthony Fauci warns Americans shouldn’t assume hydroxychloroquine is a ‘knockout drug’ PUBLISHED FRI, APR 3 202010:27 AM EDTUPDATED FRI, APR 3 202011:28 AM EDT Berkeley Lovelace Jr. @BERKELEYJR Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci speaks during the daily briefing on the novel coronavirus, COVID-19, in the Brady Briefing Room at the White House on April 1, 2020, in Washington, DC. Mandel Ngan \| AFP \| Getty Images Americans shouldn’t assume hydroxychloroquine is a “knockout drug” in preventing or treating COVID-19, White House health advisor Dr. Anthony Fauci warned Friday. “We still need to do the definitive studies to determine whether any intervention, not just this one, is truly safe and effective,” Fauci, the director of the National Institute of Allergy and Infectious Diseases, said on Fox News. “But when you don’t have that information, it’s understandable why people might want to take something anyway even with the slightest hint of being effective.” New York state last week began the first large-scale clinical trial looking at hydroxychloroquine as a possible treatment for the coronavirus after the Food and Drug Administration fast-tracked the approval process. President Donald Trump has said chloroquine and hydroxychloroquine could be a “game-changer,” even though the drugs have not been put through rigorous clinical trials to fight CV-19, which has infected more than 1 million people worldwide in a little over three months. Trump last month directed the FDA to examine whether the drugs can be used to prevent or treat the coronavirus.

To: carranza2 who wrote (155881)	4/3/2020 8:37:56 PM
From: Dr. Voodoo	Respond to of 217786

Agree mostly, but really need to follow death rate vs. cases to get a picture, which will emerge on back of distancing so it will be confounded to the public, but hopefully not in all data. Probably difficult in 2 weeks, but at most 3. Three things: 1 It is already approved-- so they don't really need trials except for dosing and treatment optimization. 2 Doesn't stop you from getting infected. 3 supply is still the main issue Prophylactic i don't believe is going to happen. First do no harm, and supply being biggest barriers. Azithromycin is also requirement based on responses for people with pneumonia. Early and higher dosing when patients present is probably going to be standard of care, this comes with risks. I would expect other treatment regimens to also emerge. I do not expect virus will disappear.